• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在受到致病性猿猴-人类免疫缺陷病毒攻击的恒河猴中,占主导地位的CD8 + T淋巴细胞反应会抑制疫苗引发的次要T淋巴细胞的扩增。

Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus.

作者信息

Manuel Edwin R, Yeh Wendy W, Seaman Michael S, Furr Kathryn, Lifton Michelle A, Hulot Sandrine L, Autissier Patrick, Letvin Norman L

机构信息

Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, E/CLS Room 1043, Boston, Massachusetts 02215, USA.

出版信息

J Virol. 2009 Oct;83(19):10028-35. doi: 10.1128/JVI.01015-09. Epub 2009 Jul 29.

DOI:10.1128/JVI.01015-09
PMID:19641002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2748023/
Abstract

Emerging data suggest that a cytotoxic T-lymphocyte response against a diversity of epitopes confers greater protection against a human immunodeficiency virus/simian immunodeficiency virus infection than does a more focused response. To facilitate the creation of vaccine strategies that will generate cellular immune responses with the greatest breadth, it will be important to understand the mechanisms employed by the immune response to regulate the relative magnitudes of dominant and nondominant epitope-specific cellular immune responses. In this study, we generated dominant Gag p11C- and subdominant Env p41A-specific CD8(+) T-lymphocyte responses in Mamu-A01(+) rhesus monkeys through vaccination with plasmid DNA and recombinant adenovirus encoding simian-human immunodeficiency virus (SHIV) proteins. Infection of vaccinated Mamu-A01(+) rhesus monkeys with a SHIV Gag Deltap11C mutant virus generated a significantly increased expansion of the Env p41A-specific CD8(+) T-lymphocyte response in the absence of secondary Gag p11C-specific CD8(+) T-lymphocyte responses. These results indicate that the presence of the Gag p11C-specific CD8(+) T-lymphocyte response following virus challenge may exert suppressive effects on primed Env p41A-specific CD8(+) T-lymphocyte responses. These findings suggest that immunodomination exerted by dominant responses during SHIV infection may diminish the breadth of recall responses primed during vaccination.

摘要

新出现的数据表明,针对多种表位的细胞毒性T淋巴细胞反应比更具针对性的反应能提供更强的抗人类免疫缺陷病毒/猴免疫缺陷病毒感染的保护作用。为了促进制定能够产生最广泛细胞免疫反应的疫苗策略,了解免疫反应用于调节显性和非显性表位特异性细胞免疫反应相对强度的机制将非常重要。在本研究中,我们通过用编码猿猴-人类免疫缺陷病毒(SHIV)蛋白的质粒DNA和重组腺病毒对Mamu-A01(+)恒河猴进行疫苗接种,产生了显性Gag p11C和亚显性Env p41A特异性CD8(+) T淋巴细胞反应。用SHIV Gag Deltap11C突变病毒感染接种疫苗的Mamu-A01(+)恒河猴,在没有继发性Gag p11C特异性CD8(+) T淋巴细胞反应的情况下,Env p41A特异性CD8(+) T淋巴细胞反应显著增加。这些结果表明,病毒攻击后Gag p11C特异性CD8(+) T淋巴细胞反应的存在可能对预先致敏的Env p41A特异性CD8(+) T淋巴细胞反应产生抑制作用。这些发现表明,SHIV感染期间显性反应施加的免疫优势可能会减少疫苗接种期间引发的回忆反应的广度。

相似文献

1
Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus.在受到致病性猿猴-人类免疫缺陷病毒攻击的恒河猴中,占主导地位的CD8 + T淋巴细胞反应会抑制疫苗引发的次要T淋巴细胞的扩增。
J Virol. 2009 Oct;83(19):10028-35. doi: 10.1128/JVI.01015-09. Epub 2009 Jul 29.
2
A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.一种具有复制能力的腺病毒5型宿主范围突变体-猴免疫缺陷病毒(SIV)重组初免/亚单位蛋白加强疫苗方案可诱导Mamu-A*01恒河猴对显性和隐性表位产生广泛、持久的SIV特异性细胞免疫。
J Immunol. 2003 Apr 15;170(8):4281-9. doi: 10.4049/jimmunol.170.8.4281.
3
Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys.通过对恒河猴进行DNA疫苗接种引发针对显性和隐性猿猴-人类免疫缺陷病毒表位的高频细胞毒性T淋巴细胞反应。
J Virol. 2001 Mar;75(5):2462-7. doi: 10.1128/JVI.75.5.2462-2467.2001.
4
Use of major histocompatibility complex class I/peptide/beta2M tetramers to quantitate CD8(+) cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys.利用主要组织相容性复合体I类/肽/β2微球蛋白四聚体来定量恒河猴感染猿猴-人类免疫缺陷病毒后针对显性和非显性病毒表位的CD8(+) 细胞毒性T淋巴细胞。
J Virol. 1999 Jul;73(7):5466-72. doi: 10.1128/JVI.73.7.5466-5472.1999.
5
Vaccination reduces simian-human immunodeficiency virus sequence reversion through enhanced viral control.接种疫苗可通过增强病毒控制来减少猴免疫缺陷病毒序列逆转。
J Virol. 2010 Dec;84(24):12782-9. doi: 10.1128/JVI.01193-10. Epub 2010 Sep 29.
6
Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys.重组金丝雀痘病毒疫苗在恒河猴体内引发针对猿猴免疫缺陷病毒显性和隐性表位的细胞毒性T淋巴细胞。
J Immunol. 2002 Feb 15;168(4):1847-53. doi: 10.4049/jimmunol.168.4.1847.
7
Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.携带载体的Gag和Env而非Tat在Mamu - A*01阴性恒河猴中对猿猴 - 人类免疫缺陷病毒89.6P攻击显示出有效性。
J Virol. 2005 Oct;79(19):12321-31. doi: 10.1128/JVI.79.19.12321-12331.2005.
8
Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.用猿猴免疫缺陷病毒(SIV)gag DNA疫苗接种的恒河猴在感染致病性SIV后会产生继发性细胞毒性T淋巴细胞反应并控制病毒复制。
J Virol. 2000 Aug;74(16):7485-95. doi: 10.1128/jvi.74.16.7485-7495.2000.
9
Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys.猕猴免疫缺陷病毒感染的恒河猴中优势表位特异性CD8 + T淋巴细胞反应演变中的免疫显性
J Immunol. 2006 Jan 1;176(1):319-28. doi: 10.4049/jimmunol.176.1.319.
10
Vaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV.用 DNA 疫苗接种恒河猴,随后用编码单纯免疫缺陷病毒(SIV)Gag 的腺病毒载体进行加强免疫,可延迟 SIV 经黏膜重复攻击引起的感染。
J Virol. 2019 Oct 15;93(21). doi: 10.1128/JVI.00606-19. Print 2019 Nov 1.

引用本文的文献

1
Virus Protein-Specific Immune Responses in Selective Depletion of Lymphocyte Populations Using Monoclonal Antibodies in Bolivian Squirrel Monkeys ().在玻利维亚松鼠猴中使用单克隆抗体选择性清除淋巴细胞群体时的病毒蛋白特异性免疫反应()。
Viral Immunol. 2025 Jan-Feb;38(1):12-22. doi: 10.1089/vim.2024.0080. Epub 2025 Jan 2.
2
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP.评估新型疫苗接种方案,使用编码 ME-TRAP 的病毒载体肝脏阶段疟疾疫苗。
Sci Rep. 2018 Feb 21;8(1):3390. doi: 10.1038/s41598-018-21630-4.
3
The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice.基于包膜蛋白结构域III的四价登革热疫苗在小鼠中引发的CD4 + T细胞免疫优势变化及保护作用
PLoS One. 2015 Dec 29;10(12):e0145717. doi: 10.1371/journal.pone.0145717. eCollection 2015.
4
In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations.针对中国人群的基于DNA的HIV-1多表位疫苗的计算机辅助设计
Hum Vaccin Immunother. 2015;11(3):795-805. doi: 10.1080/21645515.2015.1012017.
5
Antigenic requirement for Gag in a vaccine that protects against high-dose mucosal challenge with simian immunodeficiency virus.一种能抵御高剂量猿猴免疫缺陷病毒黏膜攻击的疫苗中Gag的抗原需求。
Virology. 2015 Feb;476:405-412. doi: 10.1016/j.virol.2014.12.027. Epub 2015 Jan 12.
6
Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1).翻译:翻译后细胞内运输决定了表达人类免疫缺陷病毒 1 型(HIV-1)Gag 抗原的 DNA 疫苗引发的免疫反应类型。
Hum Vaccin Immunother. 2013 Oct;9(10):2095-102. doi: 10.4161/hv.26009. Epub 2013 Aug 13.
7
Reverse vaccinology: developing vaccines in the era of genomics.反向疫苗学:基因组学时代的疫苗开发。
Immunity. 2010 Oct 29;33(4):530-41. doi: 10.1016/j.immuni.2010.09.017.
8
Vaccination reduces simian-human immunodeficiency virus sequence reversion through enhanced viral control.接种疫苗可通过增强病毒控制来减少猴免疫缺陷病毒序列逆转。
J Virol. 2010 Dec;84(24):12782-9. doi: 10.1128/JVI.01193-10. Epub 2010 Sep 29.
9
Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques.感染“逃逸”病毒变体损害了Mamu - B*08阳性猕猴对猿猴免疫缺陷病毒SIVmac239复制的控制。
J Virol. 2009 Nov;83(22):11514-27. doi: 10.1128/JVI.01298-09. Epub 2009 Sep 2.

本文引用的文献

1
Clonal focusing of epitope-specific CD8+ T lymphocytes in rhesus monkeys following vaccination and simian-human immunodeficiency virus challenge.接种疫苗及感染猿猴-人类免疫缺陷病毒后恒河猴中表位特异性CD8+ T淋巴细胞的克隆聚焦
J Virol. 2008 Jan;82(2):805-16. doi: 10.1128/JVI.01038-07. Epub 2007 Oct 31.
2
Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses.T细胞受体库广度对表位特异性CD8 + T淋巴细胞反应优势的贡献。
J Virol. 2006 Dec;80(24):12032-40. doi: 10.1128/JVI.01479-06. Epub 2006 Oct 11.
3
Compensatory substitutions restore normal core assembly in simian immunodeficiency virus isolates with Gag epitope cytotoxic T-lymphocyte escape mutations.补偿性替代可恢复具有Gag表位细胞毒性T淋巴细胞逃逸突变的猿猴免疫缺陷病毒分离株中的正常核心组装。
J Virol. 2006 Aug;80(16):8168-77. doi: 10.1128/JVI.00068-06.
4
Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines.免疫显性与免疫主导:开发有效的基于CD8 + T细胞的癌症疫苗的关键因素。
Adv Cancer Res. 2006;95:203-47. doi: 10.1016/S0065-230X(06)95006-4.
5
Immunodomination in the evolution of dominant epitope-specific CD8+ T lymphocyte responses in simian immunodeficiency virus-infected rhesus monkeys.猕猴免疫缺陷病毒感染的恒河猴中优势表位特异性CD8 + T淋巴细胞反应演变中的免疫显性
J Immunol. 2006 Jan 1;176(1):319-28. doi: 10.4049/jimmunol.176.1.319.
6
The high frequency Indian rhesus macaque MHC class I molecule, Mamu-B*01, does not appear to be involved in CD8+ T lymphocyte responses to SIVmac239.高频印度恒河猴MHC I类分子Mamu - B*01似乎未参与CD8 + T淋巴细胞对SIVmac239的应答。
J Immunol. 2005 Nov 1;175(9):5986-97. doi: 10.4049/jimmunol.175.9.5986.
7
The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance.MHC II类分子:肽复合物的动力学稳定性是决定免疫显性的关键参数。
Immunity. 2005 Jul;23(1):29-40. doi: 10.1016/j.immuni.2005.05.009.
8
Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys.多分支1型人类免疫缺陷病毒包膜免疫原在恒河猴中引发广泛的细胞免疫和体液免疫。
J Virol. 2005 Mar;79(5):2956-63. doi: 10.1128/JVI.79.5.2956-2963.2005.
9
Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.鉴定出17个由高频分子Mamu - A*02限制的新的猿猴免疫缺陷病毒衍生的CD8 + T细胞表位以及潜在的CTL识别逃逸情况。
J Immunol. 2004 Oct 15;173(8):5064-76. doi: 10.4049/jimmunol.173.8.5064.
10
The many important facets of T-cell repertoire diversity.T细胞受体库多样性的诸多重要方面。
Nat Rev Immunol. 2004 Feb;4(2):123-32. doi: 10.1038/nri1292.